IL40785A - Pharmaceutical compositions comprising 2-p-chlorophenoxy-2-methyl-propionic acid and tocopherol - Google Patents
Pharmaceutical compositions comprising 2-p-chlorophenoxy-2-methyl-propionic acid and tocopherolInfo
- Publication number
- IL40785A IL40785A IL40785A IL4078572A IL40785A IL 40785 A IL40785 A IL 40785A IL 40785 A IL40785 A IL 40785A IL 4078572 A IL4078572 A IL 4078572A IL 40785 A IL40785 A IL 40785A
- Authority
- IL
- Israel
- Prior art keywords
- composition
- tocopherol
- chlorophenoxy
- ester
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1382587 Blood cholesterol-lowering medicines IMPERIAL CHEMICAL INDUSTRIES Ltd 30 Oct 1972 [16 Dec 1971] 58398/71 Heading A5B Pharmaceutical compositions having hypocholesterolemic and serum triglyceride-lowering action comprise 2-p-chlorophenoxy-2- methylpropionic acid or an ester, amide or salt thereof and from 10 to 25% by weight thereof of a tocopherol having vitamin A activity, e.g. α-, #-, γ- or #-tocopherol, esters thereof and mixtures. Suitable esters of the propionic acid derivatives include those with alcohols R'OH where R' is piperidyl or alkyl substituted by pyridyl or nicotinoyloxy groups. The compositions may be in conventional orally administrable forms comprising the axial excipients and carriers.
[GB1382587A]
Claims (9)
1. A pharmaceutical composition comprising 2-p-chloro-phenoxy-2-methylpropionic acid, the ethyl or 1 , 3-trimethylene di-ester thereof or the sodium, potassium or calcium salt or the aluminium hydroxide di-salt thereof, and from 10% to 25% of the weight thereof of a tocopherol possessing vitamin E activity or an ester thereof, in pharmaceutically acceptable form.
2. A composition as claimed in claim 1 wherein the pharmaceutically acceptable form is a mixture together with a pharmaceutically acceptable diluent.
3. A composition as claimed in claim 2 which is in the form of a tablet, capsule, suspension, emulsion, dispersible powder, syrup or elixir.
4. A composition as claimed in claim 1 wherein the pharmaceutically acceptable form is a dosage unit in which the active ingredients are enclosed without any additional diluent.
5. A composition as claimed in claim 4 which is in the form of a capsule.
6. A composition as claimed in any preceding claim y- or J"-tocopherol or a mixture thereof, and the ester of a tocopherol is an ester with acetic acid or succinic acid.
7. A composition as claimed in claim 6 comprising active ingredients ethyl 2-p-chlorophenoxy-2-methylpropionate and DL- -tocopheryl acetate. 40785/3"
8. A composition as claimed in claim 7 which is in the form of a gelatin capsule containing 425 mg. of ethyl 2-p-chlorophenoxy-2-methylpropionate and 75-80 mg. of DL-to^-tocopheryl acetate.
9. A composition as claimed in claim 1 substantially as described in Example 1. S.HOROWITZ S CD. AGENTS FOR APPLICANTS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5839871A GB1382587A (en) | 1971-12-16 | 1971-12-16 | Pharmaceutical compositions comprising 2-rho-chlorophenoxy-2- methylpropionic acid or a derivative and a tocopherol possessing vitamin e activity |
Publications (2)
Publication Number | Publication Date |
---|---|
IL40785A0 IL40785A0 (en) | 1973-02-28 |
IL40785A true IL40785A (en) | 1976-02-29 |
Family
ID=10481514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL40785A IL40785A (en) | 1971-12-16 | 1972-11-09 | Pharmaceutical compositions comprising 2-p-chlorophenoxy-2-methyl-propionic acid and tocopherol |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPS4867420A (en) |
AU (1) | AU470387B2 (en) |
BE (1) | BE792855A (en) |
CA (1) | CA981579A (en) |
DE (1) | DE2261504A1 (en) |
FR (1) | FR2163736B1 (en) |
GB (1) | GB1382587A (en) |
IE (1) | IE36820B1 (en) |
IL (1) | IL40785A (en) |
NL (1) | NL7216837A (en) |
ZA (1) | ZA727855B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2730231B1 (en) * | 1995-02-02 | 1997-04-04 | Fournier Sca Lab | COMBINATION OF FENOFIBRATE AND VITAMIN E, USE IN THERAPEUTICS |
-
0
- BE BE792855D patent/BE792855A/en unknown
-
1971
- 1971-12-16 GB GB5839871A patent/GB1382587A/en not_active Expired
-
1972
- 1972-11-02 IE IE1489/72A patent/IE36820B1/en unknown
- 1972-11-06 ZA ZA727855A patent/ZA727855B/en unknown
- 1972-11-09 IL IL40785A patent/IL40785A/en unknown
- 1972-11-10 AU AU48736/72A patent/AU470387B2/en not_active Expired
- 1972-11-16 CA CA156,665A patent/CA981579A/en not_active Expired
- 1972-12-12 NL NL7216837A patent/NL7216837A/xx not_active Application Discontinuation
- 1972-12-15 JP JP47126036A patent/JPS4867420A/ja active Pending
- 1972-12-15 FR FR7244922A patent/FR2163736B1/fr not_active Expired
- 1972-12-15 DE DE19722261504 patent/DE2261504A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GB1382587A (en) | 1975-02-05 |
IE36820B1 (en) | 1977-03-02 |
AU4873672A (en) | 1974-05-16 |
NL7216837A (en) | 1973-06-19 |
FR2163736A1 (en) | 1973-07-27 |
JPS4867420A (en) | 1973-09-14 |
ZA727855B (en) | 1973-08-29 |
BE792855A (en) | 1973-06-15 |
AU470387B2 (en) | 1976-03-11 |
DE2261504A1 (en) | 1973-06-28 |
CA981579A (en) | 1976-01-13 |
FR2163736B1 (en) | 1976-03-05 |
IE36820L (en) | 1973-06-16 |
IL40785A0 (en) | 1973-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2003526595A5 (en) | ||
GB1389814A (en) | Cysteine derivatives and production thereof | |
EP0295637B1 (en) | Lipid regulating compositions | |
US4234601A (en) | Analgesic potentiation | |
US4233316A (en) | Analgesic potentiation | |
US4233314A (en) | Analgesic potentiation | |
AP460A (en) | Naphthyl derivative for treatment method. | |
US3144387A (en) | Anti-inflammatory compositions | |
IL40785A (en) | Pharmaceutical compositions comprising 2-p-chlorophenoxy-2-methyl-propionic acid and tocopherol | |
PT85871B (en) | Process for the preparation of orally administrable pharmaceutical compositions which contain chenodeoxycholic acid or deoxycholic acid or a salt of either of these acids any of wich may be used alone or is combination with a synergist | |
US3917832A (en) | Compositions comprising d-thyroxine and d-triiodothyronine | |
US4590183A (en) | Gastric cytoprotection with sodium thiosulfate in oral administration of aspirin | |
GB1411701A (en) | Compositions containing compounds of the eburnane structure | |
GB1456324A (en) | Cycloalkyl phenoxy carboxylic acid derivatives processes for producing them and compositions containing them | |
US2910403A (en) | Anti hypertensive compositions comprising 2-methyl-5, 8-dimethoxychromone and acetamides | |
GB955627A (en) | Therapeutic composition comprising antibiotics | |
US4585764A (en) | Gastric cytoprotection with 3,3'-thiobis[propanoic acid] in oral administration of aspirin | |
US3013942A (en) | Therapeutic erythromycin ester compositions | |
KR840006810A (en) | Process for preparing cephalosporin ester | |
IE34275B1 (en) | Alpha-hydrazino acids | |
US3703580A (en) | Antibacterial medicinal compositions | |
GB890638A (en) | Compositions for combating retinitis pigmentosa | |
GB1280244A (en) | Serum triglyceride-lowering compositions | |
JPH09169642A (en) | Tetrahydrozolilne-containing solution | |
JPS6123796B2 (en) |